These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12491820)

  • 1. Cyclooxygenase-2 inhibitor inhibits the fracture healing.
    Endo K; Sairyo K; Komatsubara S; Sasa T; Egawa H; Yonekura D; Adachi K; Ogawa T; Murakami R; Yasui N
    J Physiol Anthropol Appl Human Sci; 2002 Sep; 21(5):235-8. PubMed ID: 12491820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 inhibitor delays fracture healing in rats.
    Endo K; Sairyo K; Komatsubara S; Sasa T; Egawa H; Ogawa T; Yonekura D; Murakami R; Yasui N
    Acta Orthop; 2005 Aug; 76(4):470-4. PubMed ID: 16195060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
    J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of COX-2-specific inhibition on fracture-healing in the rat femur.
    Brown KM; Saunders MM; Kirsch T; Donahue HJ; Reid JS
    J Bone Joint Surg Am; 2004 Jan; 86(1):116-23. PubMed ID: 14711953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Aspenberg P
    J Orthop Res; 2004 May; 22(3):684; author reply 685. PubMed ID: 15099653
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters.
    Tsuneoka N; Tajima Y; Kitazato A; Fukuda K; Kitajima T; Kuroki T; Onizuka S; Kanematsu T
    Carcinogenesis; 2005 Feb; 26(2):465-9. PubMed ID: 15498790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.
    Takahashi H; Yanagi Y; Tamaki Y; Uchida S; Muranaka K
    Biochem Biophys Res Commun; 2004 Dec; 325(2):461-6. PubMed ID: 15530415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative effect of parecoxib on bone mineral during fracture healing in rats.
    Dimmen S; Nordsletten L; Engebretsen L; Steen H; Madsen JE
    Acta Orthop; 2008 Jun; 79(3):438-44. PubMed ID: 18626809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical application of cyclooxygenase-2 inhibitors].
    Dzielska-Olczak M; Olczak S
    Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model.
    Suyama H; Kawamoto M; Gaus S; Yuge O
    Brain Res; 2004 Jun; 1010(1-2):144-50. PubMed ID: 15126127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.
    Kishimoto Y; Takata N; Jinnai T; Morisawa T; Shiota G; Kawasaki H; Hasegawa J
    Gut; 2000 Dec; 47(6):812-9. PubMed ID: 11076880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.
    Chen WS; Wei SJ; Liu JM; Hsiao M; Kou-Lin J; Yang WK
    Int J Cancer; 2001 Mar; 91(6):894-9. PubMed ID: 11275997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
    Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
    J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1.
    Glaser K; Sung ML; O'Neill K; Belfast M; Hartman D; Carlson R; Kreft A; Kubrak D; Hsiao CL; Weichman B
    Eur J Pharmacol; 1995 Jul; 281(1):107-11. PubMed ID: 8566109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parecoxib and indomethacin delay early fracture healing: a study in rats.
    Dimmen S; Nordsletten L; Madsen JE
    Clin Orthop Relat Res; 2009 Aug; 467(8):1992-9. PubMed ID: 19319614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of selective cyclooxygenase-2 inhibitors, nimesulide and etodolac, on the development of squamous cell dysplasias and carcinomas of the tongue in rats initiated with 4-nitroquinoline 1-oxide.
    Yamamoto K; Kitayama W; Denda A; Morisaki A; Kuniyasu H; Kirita T
    Cancer Lett; 2003 Sep; 199(2):121-9. PubMed ID: 12969784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cox-2 inhibitors and fracture healing: an argument against such an effect.
    Hochberg MC; Melin JM; Reicin A
    J Bone Miner Res; 2003 Mar; 18(3):583; author reply 584-7. PubMed ID: 12619945
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of nail rigidity on fracture healing. Strength and mineralisation in rat femoral bone.
    Utvåg SE; Reikerås O
    Arch Orthop Trauma Surg; 1998; 118(1-2):7-13. PubMed ID: 9833097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing.
    Simon AM; O'Connor JP
    J Bone Joint Surg Am; 2007 Mar; 89(3):500-11. PubMed ID: 17332098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.